195 related articles for article (PubMed ID: 33010699)
1. Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer.
Zhang H; Wang Y; Wang Y; Wu D; Lin E; Xia Q
Pathol Res Pract; 2020 Nov; 216(11):153229. PubMed ID: 33010699
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks.
Ge X; Wang H; Zeng H; Jin X; Sujie A; Xu C; Liu Y; Huang J; Ji Y; Tan Y; Liu T; Hou Y; Qin J; Sun Y; Qin X
Hum Pathol; 2015 Jun; 46(6):850-7. PubMed ID: 25863425
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H
Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case.
Saito T; Kondo C; Shitara K; Ito Y; Saito N; Ikehara Y; Yatabe Y; Yamamichi K; Tanaka H; Nakanishi H
Pathol Int; 2015 Jun; 65(6):309-17. PubMed ID: 25828363
[TBL] [Abstract][Full Text] [Related]
5. HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks.
Xu C; Liu Y; Jiang D; Ge X; Zhang Y; Su J; Zeng H; Huang J; Ji Y; Hou J; Sun Y; Shen K; Liu T; Hou Y; Qin J
Histopathology; 2017 Oct; 71(4):570-579. PubMed ID: 28513868
[TBL] [Abstract][Full Text] [Related]
6. A novel gene-protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity.
Nishida Y; Kuwata T; Nitta H; Dennis E; Aizawa M; Kinoshita T; Ohtsu A; Ochiai A
Gastric Cancer; 2015 Jul; 18(3):458-66. PubMed ID: 24917219
[TBL] [Abstract][Full Text] [Related]
7. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays.
Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C
World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K
Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390
[TBL] [Abstract][Full Text] [Related]
9. Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer.
Tominaga N; Gotoda T; Hara M; Hale MD; Tsuchiya T; Matsubayashi J; Kono S; Kusano C; Itoi T; Fujimoto K; Moriyasu F; Grabsch HI
Gastric Cancer; 2016 Apr; 19(2):553-560. PubMed ID: 25987463
[TBL] [Abstract][Full Text] [Related]
10. Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual-color in situ hybridization.
Kanayama K; Imai H; Yoneda M; Hirokawa YS; Shiraishi T
Cancer Sci; 2016 Apr; 107(4):536-42. PubMed ID: 26752196
[TBL] [Abstract][Full Text] [Related]
11. HER2 in resected gastric cancer: Is there prognostic value?
Fisher SB; Fisher KE; Squires MH; Patel SH; Kooby DA; El-Rayes BF; Cardona K; Russell MC; Staley CA; Farris AB; Maithel SK
J Surg Oncol; 2014 Feb; 109(2):61-6. PubMed ID: 24122802
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the University Teaching Hospital, Lusaka, Zambia.
Kasochi C; Julius P; Mweemba I; Kayamba V
Afr Health Sci; 2020 Dec; 20(4):1857-1864. PubMed ID: 34394249
[TBL] [Abstract][Full Text] [Related]
13. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
Shan L; Ying J; Lu N
Diagn Pathol; 2013 May; 8():76. PubMed ID: 23656792
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.
Zhang XL; Yang YS; Xu DP; Qu JH; Guo MZ; Gong Y; Huang J
World J Surg; 2009 Oct; 33(10):2112-8. PubMed ID: 19636613
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in Gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.
Yang J; Luo H; Li Y; Li J; Cai Z; Su X; Dai D; Du W; Chen T; Chen M
Cell Biochem Biophys; 2012 Jan; 62(1):221-8. PubMed ID: 21927816
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of HER2 amplification and overexpression in early onset gastric cancer.
Moelans CB; Milne AN; Morsink FH; Offerhaus GJ; van Diest PJ
Cell Oncol (Dordr); 2011 Apr; 34(2):89-95. PubMed ID: 21394646
[TBL] [Abstract][Full Text] [Related]
18. HER2, NF-
Smolińska M; Grzanka D; Antosik P; Kasperska A; Neska-Długosz I; Jóźwicki J; Klimaszewska-Wiśniewska A
Dis Markers; 2019; 2019():6315936. PubMed ID: 31737131
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of intratumoral HER2 heterogeneity in gastric cancer.
Lee HE; Park KU; Yoo SB; Nam SK; Park DJ; Kim HH; Lee HS
Eur J Cancer; 2013 Apr; 49(6):1448-57. PubMed ID: 23146959
[TBL] [Abstract][Full Text] [Related]
20. Tumor Heterogeneity Index to Detect Human Epidermal Growth Factor Receptor 2 Amplification by Next-Generation Sequencing: A Direct Comparison Study with Immunohistochemistry.
Choi S; Chu J; Kim B; Ha SY; Kim ST; Lee J; Kang WK; Han H; Sohn I; Kim KM
J Mol Diagn; 2019 Jul; 21(4):612-622. PubMed ID: 31022472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
